GlaxoSmithKline Successfully Rolls Out Lumesse TalentLink As Part of its Recruitment Strategy in Greater China

Lumesse Selected Based on Superior Local Service and Proven Expertise in Greater China

AUSTIN, Texas & SHANGHAI & LONDON--()--Lumesse, a global leader in integrated talent management solutions, today announced that GlaxoSmithKline (GSK) has implemented Lumesse TalentLink as the core technology platform supporting the shared HR-service team building its Greater China talent acquisition strategy.

The GSK talent acquisition team has a strategic goal to transform its recruitment processes to enable it to build a robust talent pipeline. Current market growth has driven over 2,000 hires for GSK across Beijing, Shanghai, Guangzhou, Tianjing and Hong Kong within the last year.

As part of the GSK global recruitment solution implementation, the Lumesse China team took just three months in early 2011 to implement Lumesse TalentLink solutions locally in a project that included system tests and user training. Lumesse TalentLink now supports 18 recruiters, more than 10 HR business partners and 10 agencies across the Greater China region.

“To allow us to manage the China market, the evolution of the HR team into a shared-service unit pairs up recruiters with business managers as close partners,” noted Blake Cai, recruitment & HRIS manager, HR Shared Services, GSK Greater China. “Meanwhile, we are conscious that this model has to be balanced with stronger centralization across cities to drive efficiency.”

Since staff referral is a very important hiring channel in the pharmaceutical industry, the GSK team makes creative use of the Lumesse TalentLink platform to publicize job advertisements among existing staff. The platform is also connected to the two largest job-boards in China, 51jobs and Zhaopin to effectively manage job applications through this channel. The scalability and flexibility of the Lumesse platform has also enabled GSK to offer a better candidate experience in the application process for the large number of applications it receives. For example, as a famous consumer brand in pharmaceuticals, the capability to improve rejection handling for GSK recruiters was a key factor in choosing Lumesse TalentLink.

“High growth markets like China are driving global brands to rethink talent strategies,” said Lumesse CEO Matthew Parker. “The need to combine both high-volume and specialists skills when recruiting puts huge demands on managers and HR professionals. Operational efficiency and the ability to tap into multiple sourcing channels are key benefits that Lumesse TalentLink can deliver.”

“Our recruiters have always been professional and productive, but they needed to change as our business expands rapidly,” added Cai. “What worked in the past with isolated spreadsheets will now be replaced with a single, regionally shared talent acquisition platform that provides better information transparency and standardized workflows. We believe that the better data integrity, accuracy and analytical reports that have come after the change have genuinely improved the shared-service team’s working lead time, cost and service delivery and made it a better partner with the GSK business.”

GSK chose Lumesse among many local and global solution vendors based on its better local service and proven expertise in Greater China. Product functionality, operational speed and project cost-effectiveness were prime considerations as well.

“The China market is filled with opportunities and challenges,” noted Erik Schmit, managing director of APAC Region, Lumesse. “The commitment of Lumesse in the China market with continuous investment in its local services team and infrastructure differentiates us from the rest. This was is a key reason for GSK extending its cooperation with us outside of its headquarters region.”

About GSK

GSK is one of the world's leading research-based pharmaceutical and healthcare companies. Headquartered in the UK, GSK is a global organization with offices in over 100 countries, employing 96,500 people. Over 13,000 people work in our research teams to discover new medicines, with major research centres in the UK, USA, Belgium and China. GSK’s vaccines are included in immunization campaigns in 182 countries worldwide. In year 2010 alone, GSK delivered 1.4 billion vaccine doses to 179 countries. GSK is committed to tackling the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria. In the developing world, GSK provide certain medicines at preferential prices ensuring that the poorest can still benefit from their treatments and vaccines

About Lumesse

Lumesse is the only global company making talent management solutions work locally. We help customers around the world to implement successful local talent management initiatives that identify, nurture and develop the right people, in the right place, at the right time. Our multi-cultural background and presence means we understand how to deliver talent solutions that work the way our customers work, as individuals and as teams, because no two people, organizations or cultures are the same. We regard differences as strengths, not as obstacles.

1,900 customers work with us in over 70 countries because they recognize that commitment, innovation and value only come from people. We help customers to unlock and inspire that human potential in their businesses. Our integrated talent management solutions are comprehensive, intuitive, secure and fully internationalized into over 50 languages.


Product information:

Read our blog at:

Twitter: @Lumesse_us


GCC, Inc. (for Lumesse)
George Cohen, 617-325-0011

Release Summary

Lumesse announced that GlaxoSmithKline has implemented Lumesse TalentLink as the core technology platform supporting the shared HR-service team.


GCC, Inc. (for Lumesse)
George Cohen, 617-325-0011